Can-Fite BioPharma Ltd. Net Foreign Exchange Loss
Can-Fite BioPharma Ltd. (CANF) reported Net Foreign Exchange Loss of $28.00 thousand for the 12-month period ending 2019-12-31, per its 20-F filed 2020-03-27.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:NetForeignExchangeLoss · last filed 2020-03-27
| Period end | Net Foreign Exchange Loss 12 month |
|---|---|
| 2019-12-31 | $28.00K 20-F · filed 2020-03-27 |
| 2018-12-31 | $115.00K 20-F · filed 2020-03-27 |
| 2017-12-31 | $588.00K 20-F · filed 2020-03-27 |
| 2016-12-31 | $16.00K 20-F · filed 2019-03-29 |